1. HBW Insight
  2. >>Health
  3. >>Rx-to-OTC Switch

Recordati Launches Fortacin OTC In Germany Following EU-Wide Switch

 
• By Tom Gallen

Men in Germany can now purchase premature ejaculation treatment Fortacin without a prescription as a result of the EU-wide switch of the drug earlier this year.

Close-up of colored map of Europe zoomed in on Germany
• Source: Shutterstock

Recordati has launched its premature ejaculation treatment Fortacin as an OTC product in Germany following an EU-wide switch through the European Medicines Agency’s centralized procedure.

While the European Commission in August approved the reclassification of Fortacin all 27 EU member states, plus in the European...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Rx-to-OTC Switch

German Switch Committee Supports OTC Melatonin And Acyclovir, Rejects Rupatadine

 
• By David Ridley

Germany’s Expert Committee for Prescription supports the Rx-to-OTC switches of melatonin and buccal acyclovir but rejects rupatadine.

Navamedic To Market OTC Naloxone In Norway Following Switch

 
• By Tom Gallen

Navamedic adds Ventizolve to its portfolio shortly after Norway switched the opioid overdose reversal drug from Rx to OTC.

Viatris Switches Innovative Dual Action Nasal Spray In The UK

 
• By David Ridley

Now available without a prescription, Dymista Control is the first OTC combination treatment for consumers who are struggling to control their seasonal allergic rhinitis with a corticosteroid or antihistamine nasal spray, according to the firm.

Haleon Study: Self-Care Policies Could Save Finland €60m Per Year

 
• By David Ridley

Creating a working group to drive Rx-to-OTC switch is one of the ways in which Finland could expand self-care and save €60m per year for the country's health system, suggests a recently published report commissioned by Haleon.

More from Health

US FDA Maintaining Approval Output Despite Losing Staff

 
• By Derrick Gingery

Reviewers were not targeted by the FDA reduction in force, but increasing attrition and difficulties hiring new staff still do not seem to have impacted new and generic drug approval totals.

German Quaternary Wastewater Treatment Cost Estimates ‘Not Realistic’

 
• By David Ridley

Updating wastewater treatment facilities in Germany will cost almost three times more than the German Association of Local Public Utilities (VKU) has predicted, according to a Pharma Deutschland analysis.

Kenvue Report: Personal Care Is ‘Not A Luxury’, It Is Now A ‘Cornerstone Of Health’

 
• By David Ridley

“Today’s consumers, especially younger generations, are redefining personal care as preventive care,” argues Kenvue on the basis of its latest research into global consumer trends.